Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-25 of 162 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Early Natural History of Cardiomyopathy and Cardiac Stress Response in Young Dogs with Golden Retriever Muscular Dystrophy
Guo L, Nghiem PP, Bettis AK, Soslow JH, Spurney CF, Kornegay JN
bioRxiv, 20 Aug 2024
Cited by: 0 articles | PPR: PPR900251
Add to export list Preprint
Longitudinal assessment of skeletal muscle functional mechanics in the DE50-MD dog model of Duchenne muscular dystrophy.
Riddell DO, Hildyard JCW, Harron RCM, Taylor-Brown F, Kornegay JN, Wells DJ, Piercy RJ
Dis Model Mech, 16(12):dmm050395, 20 Dec 2023
Cited by: 2 articles | PMID: 38050706 | PMCID: PMC10753191
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy.
Birch SM, Lawlor MW, Conlon TJ, Guo LJ, Crudele JM, Hawkins EC, Nghiem PP, Ahn M, Meng H, Beatka MJ, Fickau BA, Prieto JC, Styner MA, Struharik MJ, Shanks C, Brown KJ, Golebiowski D, Bettis AK, Balog-Alvarez CJ, [...] Kornegay JN
Sci Transl Med, 15(677):eabo1815, 04 Jan 2023
Cited by: 23 articles | PMID: 36599002
Add to export list
Natural History of Histopathologic Changes in Cardiomyopathy of Golden Retriever Muscular Dystrophy.
Schneider SM, Sansom GT, Guo LJ, Furuya S, Weeks BR, Kornegay JN
Front Vet Sci, 8:759585, 17 Feb 2022
Cited by: 3 articles | PMID: 35252412 | PMCID: PMC8892215
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A Dystrophin Exon-52 Deleted Miniature Pig Model of Duchenne Muscular Dystrophy and Evaluation of Exon Skipping.
Echigoya Y, Trieu N, Duddy W, Moulton HM, Yin H, Partridge TA, Hoffman EP, Kornegay JN, Rohret FA, Rogers CS, Yokota T
Int J Mol Sci, 22(23):13065, 02 Dec 2021
Cited by: 10 articles | PMID: 34884867 | PMCID: PMC8657897
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.
Martin PT, Zygmunt DA, Ashbrook A, Hamilton S, Packer D, Birch SM, Bettis AK, Balog-Alvarez CJ, Guo LJ, Nghiem PP, Kornegay JN
PLoS One, 16(3):e0248721, 26 Mar 2021
Cited by: 5 articles | PMID: 33770101 | PMCID: PMC7997012
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Muscle-specific deletion of SLK/Stk2 enhances p38 activity and myogenesis in mdx mice.
Pryce BR, Labrèche C, Hamoudi D, Abou-Hamad J, Abou-Hamad J, Al-Zahrani KN, Hodgins JJ, Boulanger-Piette A, Bossé S, Balog-Alvarez C, Frénette J, Ardolino M, Kornegay JN, Sabourin LA
Biochim Biophys Acta Mol Cell Res, 1868(2):118917, 28 Nov 2020
Cited by: 1 article | PMID: 33259860
Add to export list
Parent Project Muscular Dystrophy Females with Dystrophinopathy Conference, Orlando, Florida June 26 - June 27, 2019.
Apkon S, Kinnett K, Cripe L, Duan D, Jackson JL, Kornegay JN, Mah ML, Nelson SF, Rao V, Scavina M, Wong BL, Flanigan KM
J Neuromuscul Dis, 8(2):315-322, 01 Jan 2021
Cited by: 4 articles | PMID: 33361607 | PMCID: PMC10497321
Add to export list Free full text in Europe PMC
Using MRI to quantify skeletal muscle pathology in Duchenne muscular dystrophy: A systematic mapping review.
Alic L, Griffin JF, Eresen A, Kornegay JN, Ji JX
Muscle Nerve, 64(1):8-22, 08 Jan 2021
Cited by: 10 articles | PMID: 33269474 | PMCID: PMC8247996
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy.
Terrill JR, Al-Mshhdani BA, Duong MN, Wingate CD, Abbas Z, Baustista AP, Bettis AK, Balog-Alvarez CJ, Kornegay JN, Nghiem PP, Grounds MD, Arthur PG
PLoS One, 15(10):e0240317, 08 Oct 2020
Cited by: 4 articles | PMID: 33031394 | PMCID: PMC7544076
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Correction: Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy.
Mata López S, Balog-Alvarez C, Vitha S, Bettis AK, Canessa EH, Kornegay JN, Nghiem PP
PLoS One, 15(10):e0241430, 22 Oct 2020
Cited by: 3 articles | PMID: 33091069 | PMCID: PMC7580940
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Expiratory dysfunction in young dogs with golden retriever muscular dystrophy.
Hawkins EC, Bettis AK, Kornegay JN
Neuromuscul Disord, 30(11):930-937, 20 Sep 2020
Cited by: 5 articles | PMID: 33071066 | PMCID: PMC7680419
Add to export list Free full text in Europe PMC
Inter-Institutional Partnerships to Develop Veterinarian-Investigators through the NIH Comparative Biomedical Scientist Training Program Benefit One Health Goals.
Simpson RM, Hoover SB, Davis BJ, Hickerson J, Miller MA, Kiupel M, Cullen JM, Dwyer JE, Wei BR, Rosol TJ, Kornegay JN, Samal SK
J Vet Med Educ, 47(5):619-631, 01 Oct 2020
Cited by: 0 articles | PMID: 33231519
Add to export list
Correction: Expression profiling of disease progression in canine model of Duchenne muscular dystrophy.
Brinkmeyer-Langford C, Chu C, Balog-Alvarez C, Yu X, Cai JJ, Nabity M, Kornegay JN
PLoS One, 15(7):e0236916, 23 Jul 2020
Cited by: 1 article | PMID: 32702009 | PMCID: PMC7377489
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Creation and characterization of an immortalized canine myoblast cell line: Myok9.
López SM, Balog-Alvarez C, Canessa EH, Hathout Y, Brown KJ, Vitha S, Bettis AK, Boehler J, Kornegay JN, Nghiem PP
Mamm Genome, 31(3-4):95-109, 03 Apr 2020
Cited by: 3 articles | PMID: 32246189
Add to export list
Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy.
Mata López S, Balog-Alvarez C, Vitha S, Bettis AK, Canessa EH, Kornegay JN, Nghiem PP
PLoS One, 15(1):e0228072, 21 Jan 2020
Cited by: 15 articles | PMID: 31961902 | PMCID: PMC6974172
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
Song Y, Morales L, Malik AS, Mead AF, Greer CD, Mitchell MA, Petrov MT, Su LT, Choi ME, Rosenblum ST, Lu X, VanBelzen DJ, Krishnankutty RK, Balzer FJ, Loro E, French R, Propert KJ, Zhou S, Kozyak BW, [...] Stedman HH
Nat Med, 25(10):1505-1511, 07 Oct 2019
Cited by: 42 articles | PMID: 31591596 | PMCID: PMC7274039
Add to export list Free full text in Europe PMC
Laminin-111 protein therapy enhances muscle regeneration and repair in the GRMD dog model of Duchenne muscular dystrophy.
Barraza-Flores P, Fontelonga TM, Wuebbles RD, Hermann HJ, Nunes AM, Kornegay JN, Burkin DJ
Hum Mol Genet, 28(16):2686-2695, 01 Aug 2019
Cited by: 15 articles | PMID: 31179490 | PMCID: PMC6687953
Add to export list Free full text in Europe PMC
Muscle percentage index as a marker of disease severity in golden retriever muscular dystrophy.
Eresen A, Hafsa NE, Alic L, Birch SM, Griffin JF, Kornegay JN, Ji JX
Muscle Nerve, 60(5):621-628, 28 Aug 2019
Cited by: 3 articles | PMID: 31397906
Add to export list
Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy.
Guo LJ, Soslow JH, Bettis AK, Nghiem PP, Cummings KJ, Lenox MW, Miller MW, Kornegay JN, Spurney CF
J Am Heart Assoc, 8(16):e012443, 14 Aug 2019
Cited by: 14 articles | PMID: 31411085 | PMCID: PMC6759898
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Correction to: Gene therapies in canine models for Duchenne muscular dystrophy.
Nghiem PP, Kornegay JN
Hum Genet, 138(5):491, 01 May 2019
Cited by: 0 articles | PMID: 30783825
Add to export list
Gene therapies in canine models for Duchenne muscular dystrophy.
Nghiem PP, Kornegay JN
Hum Genet, 138(5):483-489, 07 Feb 2019
Cited by: 16 articles | PMID: 30734120
Add to export list Review
Texture as an imaging biomarker for disease severity in golden retriever muscular dystrophy.
Eresen A, Alic L, Birch SM, Friedeck W, Griffin JF, Kornegay JN, Ji JX
Muscle Nerve, 59(3):380-386, 13 Jan 2019
Cited by: 3 articles | PMID: 30461036
Add to export list
Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy.
Haddix SG, Lee YI, Kornegay JN, Thompson WJ
PLoS One, 13(10):e0205926, 31 Oct 2018
Cited by: 31 articles | PMID: 30379896 | PMCID: PMC6209224
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.
Schneider SM, Sridhar V, Bettis AK, Heath-Barnett H, Balog-Alvarez CJ, Guo LJ, Johnson R, Jaques S, Vitha S, Glowcwski AC, Kornegay JN, Nghiem PP
Mol Imaging Biol, 20(5):780-788, 01 Oct 2018
Cited by: 15 articles | PMID: 29508262 | PMCID: PMC6153676
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 162 results

1 2 3 Next ...

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Early Natural History of Cardiomyopathy and Cardiac Stress Response in Young Dogs with Golden Retriever Muscular Dystrophy

Longitudinal assessment of skeletal muscle functional mechanics in the DE50-MD dog model of Duchenne muscular dystrophy.

Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy.

Natural History of Histopathologic Changes in Cardiomyopathy of Golden Retriever Muscular Dystrophy.

A Dystrophin Exon-52 Deleted Miniature Pig Model of Duchenne Muscular Dystrophy and Evaluation of Exon Skipping.

Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.

Muscle-specific deletion of SLK/Stk2 enhances p38 activity and myogenesis in mdx mice.

Parent Project Muscular Dystrophy Females with Dystrophinopathy Conference, Orlando, Florida June 26 - June 27, 2019.

Using MRI to quantify skeletal muscle pathology in Duchenne muscular dystrophy: A systematic mapping review.

Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy.

Correction: Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy.

Expiratory dysfunction in young dogs with golden retriever muscular dystrophy.

Inter-Institutional Partnerships to Develop Veterinarian-Investigators through the NIH Comparative Biomedical Scientist Training Program Benefit One Health Goals.

Correction: Expression profiling of disease progression in canine model of Duchenne muscular dystrophy.

Creation and characterization of an immortalized canine myoblast cell line: Myok9.

Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy.

Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.

Laminin-111 protein therapy enhances muscle regeneration and repair in the GRMD dog model of Duchenne muscular dystrophy.

Muscle percentage index as a marker of disease severity in golden retriever muscular dystrophy.

Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy.

Correction to: Gene therapies in canine models for Duchenne muscular dystrophy.

Gene therapies in canine models for Duchenne muscular dystrophy.

Texture as an imaging biomarker for disease severity in golden retriever muscular dystrophy.

Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy.

Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.

Partnerships & funding